Key result
Cardiac magnetic resonance provides accurate assessment of valvular heart disease severity and serves as the gold standard for evaluating myocardial remodeling, particularly when echocardiography is limited.
Why the study?
CMR can overcome limitations of echocardiographic assessment in valvular heart disease, prompting a review of its role in assessing disease severity and myocardial remodeling.
CMR provides comprehensive assessment of valvular heart disease severity, ventricular remodeling, and myocardial fibrosis, overcoming limitations of echocardiography.
Answers are grounded in this paper and cite their sources.
CMR refines VHD severity assessment beyond echo; leaves open standardization for routine practice.
Cardiac magnetic resonance (CMR) has emerged as the gold standard in assessing ventricular mass, volume, and systolic function. Due to these and other strengths, CMR has increasingly been used to study valvular heart disease (VHD) and resultant cardiac remodeling. By using CMR to assess flow, limitations in echocardiographic assessment of VHD can be overcome, particularly in regurgitant lesions. The following article reviews the current role of CMR imaging in studying disease severity and myocardial remodeling in patients with VHD.
No takes yet. Share an insight, caveat, or question.
Malahfji et al. (2020) conducted a review in Valvular Heart Disease. Cardiac Magnetic Resonance (CMR) vs. Echocardiography was evaluated. Cardiac magnetic resonance provides accurate assessment of valvular heart disease severity and serves as the gold standard for evaluating myocardial remodeling, particularly when echocardiography is limited.
Synapse has enriched 10 related papers. Consider them for comparative context: